0069-0507Level 3
Xalkori (CRIZOTINIB)
**Product type:** Human Prescription Drug
**Active ingredient:** CRIZOTINIB
**Strength:** 50 mg/1
**Dosage form:** Capsule, Coated Pellets
**Route:** Oral
**Labeler:** Pfizer Laboratories Div Pfizer Inc
**Marketing category:** NDA (NDA217581)
**Pharmacologic class:** Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0069-0507Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.